Product Datasheet
www.leinco.com
excellence in early discovery research       



RP105 (Intermediate Domain) Blocking Peptide
(Radioprotective 105, Lymphocyte Antigen 64, CD180 Antigen Precursor)
Blocking Peptide
Share |

Size


Prod. No.:R1249
Conc.:0.2 mg/ml
Pkg. Size:50 µg
Storage:-20° Detailed storage instructions below.
Description
Background:
RP105 peptide is applicable as a control peptide for blocking antibody binding in Western blotting.

Amino Acid Location
14 amino acids near the center of human RP105 (1).
Formulation
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Storage and Stability
Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Reported Applications
IHC (NBF/Par.), N, WB, In vivo Depletion
Neutralization: The peptide may be used to neutralize the binding activity of Anti-Human RP105 (Intermediate Domain) (Leinco Prod. No.: R1246) by incubation of an equal volume of the peptide and antibody for 30 minutes at 37°C for Western blotting experiments.
Each investigator should determine their own optimal working dilution for specific applications.
Country of Origin
USA
References
1. Divanovic S, Trompette A, Atabani SF, et al. Inhibition of TLR-4/MD-2 signaling by RP105/MD-1. J. Endotoxin Res. 2005; 11:363-8.
Related Products
Anti-Human RP105 (Intermediate Domain) (Leinco Prod. No.: R1246)
Anti-Human RP105 (CT) (Leinco Prod. No.: R1245)
Anti-Human RP105 (NT) (Leinco Prod. No.: R1247)
RP105 (CT) Blocking Peptide (Leinco Prod. No.: R1248)
RP105 (NT) Blocking Peptide (Leinco Prod. No.: R1250)
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
359 Consort Drive | St. Louis, MO 63011 | (800) 538-1145 | (636) 527-5545 fax
800.538.1145 ® Copyright Leinco Technologies, Inc. 2006 – 2012